|
Status |
Public on Oct 27, 2021 |
Title |
Divergent leukemia sub-clones derived from U-937 cells (MBU-8) |
Sample type |
genomic |
|
|
Source name |
Cell line
|
Organism |
Homo sapiens |
Characteristics |
cell line: U-937 derived cell line MBU-7 disease state: leukemia
|
Treatment protocol |
None
|
Growth protocol |
All cell lines were cultured in RPMI 1640 (ThermoFisher Scientific) supplemented with 10%, 1% Pen/Strep, and 1% L-glutamine at 37ºC in 5% CO2. All cell lines were routinely analyzed for the presence of mycoplasma
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Genomic DNA was extracted from collected cells using PureLink Genomic DNA Mini Kit (ThermoFisher Scientific)
|
Label |
Biotin
|
Label protocol |
As per manufacturer (ThermoFisher)
|
|
|
Hybridization protocol |
DNA was restriction digested, PCR amplified, fragmented, labeled and hybridized to each array according to the manufacturer's instructions.
|
Scan protocol |
The Arrays were then washed using ThermoFisher fluidics stations, and scanned using the Gene Chip Scanner 3000.
|
Description |
Hybridized to CytoScan 750K
|
Data processing |
The array image was acquired using ThermoFihser GeneChip® Operating Software. Copy number and SNP study was performed with the Chromosome Analysis Suite (ThermoFisher, versión 4.2). Copy number and SNP data (CYCHP file)
|
|
|
Submission date |
Sep 24, 2021 |
Last update date |
Oct 27, 2021 |
Contact name |
Mar Mallo |
Organization name |
Josep Carreras Leukaemia Research Institute
|
Street address |
Ctra de Can Ruti, s/n, camí de les escoles. Edifici IMPPC
|
City |
Badalona |
ZIP/Postal code |
08916 |
Country |
Spain |
|
|
Platform ID |
GPL18637 |
Series (1) |
GSE184764 |
Divergent leukemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18 |
|